Abstract
We aimed to investigate cross-sectional associations between skeletal muscle density, a proxy measure for fatty infiltration into muscle, and cognition. Contributions from body fat mass, systemic inflammation and lifestyle were explored, as these factors have been identified in both muscle and cognitive deterioration. For 281 men (60–95 year) from the Geelong Osteoporosis Study, radial and tibial muscle density were measured using peripheral quantitative computed tomography. Body fat and appendicular lean mass were measured using dual-energy X-ray absorptiometry. Cognitive function was assessed for psychomotor function (DET), visual identification/attention (IDN), visual learning (OCL) and working memory (OBK) (CogState Brief Battery). Composite scores signified overall cognitive function (OCF). Higher scores represent poorer performance except for OCL and OCF. Regression analyses examined associations between muscle density and cognition; potential confounders included age, muscle cross-sectional area (CSA), body composition, lifestyle and serum markers of inflammation. Negative associations with age were evident for muscle density, all cognitive domains and OCF. Muscle density at both sites was positively associated with DET, OCL and OCF. After adjustment for age, the association persisted for DET (radius: B = − 0.006, p = 0.02; tibia: B = − 0.003, p = 0.04) and OCL (radius B = + 0.004, p = 0.02; tibia: B = + 0.005, p < 0.001). At the radius, further adjustment for serum TNF-α explained the association between muscle density (B = − 0.002, p = 0.66) and DET. Education and physical activity contributed to the model for radial muscle density and DET. There were no contributions from muscle CSA, appendicular lean mass, body fat mass, other markers of inflammation or other potential confounders. At the tibia, the association between muscle density and DET (B = − 0.003, p = 0.04) was independent of TNF-α. There was an age-adjusted association between muscle density and OCL at both sites (radius: B = + 0.004, p = 0.02; tibia: B = + 0.005, p < 0.001). None of the potential confounders contributed to the models. Muscle density was associated with cognitive function in the DET and OCL domains. However, there was little evidence that this was explained by inflammation or body fat mass. No associations were identified between muscle density and IDN or OBK.
Similar content being viewed by others
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Davis S, Bartlett H (2008) Review article: healthy ageing in rural Australia: Issues and challenges. Australas J Ageing 27(2):56–60
Shrivastava SR, Shrivastava PS, Ramasamy J (2013) Health-care of elderly: Determinants, needs and services. Int J Prev Med 4(10):1224–1225
Boyle PA, Buchman AS, Wilson RS, Leurgans SE, Bennett DA (2009) Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons. Arch Neurol 66(11):1339–1344
Nishiguchi S, Yamada M, Shirooka H et al (2016) Sarcopenia as a risk factor for cognitive deterioration in community-dwelling older adults: A 1-Year prospective study. J Am Med Dir Assoc 17(4):372.e375–372.e378
Goodpaster BH, Kelley DE, Thaete FL, He J (1985) Ross R (2000) Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol 89(1):104–110
Wong AK, Beattie KA, Min KK et al (2014) Peripheral quantitative computed tomography-derived muscle density and peripheral magnetic resonance imaging-derived muscle adiposity: precision and associations with fragility fractures in women. J Musculoskelet Neuronal Interact 14(4):401–410
Goodpaster BH, Kelley DE, Thaete FL, He J, Ross R (2000) Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol 89(1):104–110
Cesari M, Pahor M, Lauretani F et al (2009) Skeletal muscle and mortality results from the InCHIANTI Study. J Gerontol A Biol Sci Med Sci 64(3):377–384
Rivas DA, McDonald DJ, Rice NP, Haran PH, Dolnikowski GG, Fielding RA (2016) Diminished anabolic signaling response to insulin induced by intramuscular lipid accumulation is associated with inflammation in aging but not obesity. Am J Physiol Regul Integr Comp Physiol 310(7):R561–569
Frank-Wilson AW, Farthing JP, Chilibeck PD et al (2016) Lower leg muscle density is independently associated with fall status in community-dwelling older adults. Osteoporos Int 27(7):2231–2240
Cesari M, Leeuwenburgh C, Lauretani F et al (2006) Frailty syndrome and skeletal muscle: results from the Invecchiare in Chianti study. Am J Clin Nutr 83(5):1142–1148
Martone AM, Marzetti E, Calvani R et al (2017) Exercise and protein intake: A Synergistic approach against sarcopenia. Biomed Res Int 2017:2672435–2672435
Nourhashémi F, Andrieu S, Gillette-Guyonnet S et al (2002) Is there a relationship between fat-free soft tissue mass and low cognitive function? results from a study of 7,105 Women. J Am Geriatr Soc 50(11):1796–1801
Haddad F, Zaldivar F, Cooper DM (1985) IL-6-induced skeletal muscle atrophy. J Appl Physiol (2005) 98(3):911–917
Steensberg A, Febbraio MA, Osada T et al (2001) Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J Physiol 537:633–639
Dalle S, Rossmeislova L, Koppo K (2017) The role of inflammation in age-related sarcopenia. Front Physiol 8:1045
Lin T, Liu GA, Perez E et al (2018) Systemic Inflammation mediates age-related cognitive deficits. Front Aging Neurosci 10:236
Berk M, Williams LJ, Jacka FN et al (2013) So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 11(1):200
Yaffe K, Barnes D, Nevitt M, Lui L-Y, Covinsky K (2001) A prospective study of physical activity and cognitive decline in elderly women: Women who walk. JAMA Intern Med 161(14):1703–1708
Kimura N, Aso Y, Yabuuchi K et al (2019) Modifiable lifestyle factors and cognitive function in older people A cross-sectional observational study. Front Neurol. https://doi.org/10.3389/fneur.2019.00401
Legdeur N, Heymans MW, Comijs HC, Huisman M, Maier AB, Visser PJ (2018) Age dependency of risk factors for cognitive decline. BMC Geriatr 18(1):187–187
Pasco JA, Nicholson GC, Kotowicz MA (2011) Cohort Profile: Geelong Osteoporosis Study. Int J Epidemiol 41(6):1565–1575
Fredrickson J, Maruff P, Woodward M et al (2010) Evaluation of the usability of a brief computerized cognitive screening test in older people for epidemiological studies. Neuroepidemiology 34(2):65–75
Sui SX, Holloway-Kew KL, Hyde NK, Williams LJ, Leach S, Pasco JA (2020) Muscle strength and function rather than muscle mass are better indicators for poor cognitive performance in older men. Sci Rep 10(1):10367
Zarshenas S, Cullen N (2018) Association between cognitive ability and functional outcomes following traumatic brain injury- using a computer-based neurocognitive battery. Brain Inj 32(13–14):1678–1683
Lim YY, Villemagne VL, Laws SM et al (2016) Performance on the Cogstate Brief Battery is related to amyloid levels and Hippocampal volume in very mild dementia. J Mol Neurosci 60(3):362–370
Lim YY, Jaeger J, Harrington K et al (2013) Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS). Arch Clin Neuropsychol 28(4):320–330
Louey AG, Cromer JA, Schembri AJ et al (2014) Detecting cognitive impairment after concussion: sensitivity of change from baseline and normative data methods using the CogSport/Axon cognitive test battery. Arch Clin Neuropsychol 29(5):432–441
Blew RM, Lee VR, Farr JN, Schiferl DJ, Going SB (2014) Standardizing evaluation of pQCT image quality in the presence of subject movement: qualitative versus quantitative assessment. Calcif Tissue Int 94(2):202–211
Smith E, Hay P, Campbell L, Trollor JN (2011) A review of the association between obesity and cognitive function across the lifespan: implications for novel approaches to prevention and treatment. Obes Rev 12(9):740–755
Giles G, Ireland PD (1996) Dietary questionnaire for epidemiological studies (Version 2). The Cancer Council Victoria, Melbourne
National Health Medical Research Council. Australian guidelines to reduce health risks from drinking alcohol. Canberra A, 2009.
Voorrips L, Ravelli A, Dongelmans P, Deurenberg P (1991) A physical activity questionnaire for the elderly. MedSci Sports Exerc 23:974–979
Chang KV, Hsu TH, Wu WT, Huang KC, Han DS (2016) Association between sarcopenia and cognitive impairment A systematic review and meta-analysis. J Am Med Dir Assoc. 17(12):1164 e1167–1164 e1115
Abellan van Kan G, Cesari M, Gillette-Guyonnet S et al (2012) Sarcopenia and cognitive impairment in elderly women results from the EPIDOS cohort. Age Ageing. 42(2):196–202
Takata Y, Ansai T, Soh I et al (2008) Physical fitness and cognitive function in an 85-year-old community-dwelling population. Gerontology 54(6):354–360
Alfaro-Acha A, Al Snih S, Raji MA, Kuo Y-F, Markides KS, Ottenbacher KJ (2006) Handgrip strength and cognitive decline in older Mexican Americans. J Gerontol A Biol Sci Med Sci 61(8):859–865
Patel A, Jameson KA, Edwards MH et al (2018) Mild cognitive impairment is associated with poor physical function but not bone structure or density in late adulthood: findings from the Hertfordshire cohort study. Arch Osteoporos 13(1):44
Laudisio A, Fontana DO, Rivera C et al (2016) Bone mineral mensity and cognitive decline in elderly women: Results from the InCHIANTI Study. Calcif Tissue Int 98(5):479–488
Pasco JA, Mohebbi M, Holloway KL, Brennan-Olsen SL, Hyde NK, Kotowicz MA (2017) Musculoskeletal decline and mortality: prospective data from the Geelong Osteoporosis Study. J Cachexia Sarcopenia Muscle 8(3):482–489
Pasco JA, Holloway KL, Brennan-Olsen SL, Moloney DJ, Kotowicz MA (2015) Muscle strength and areal bone mineral density at the hip in women: a cross-sectional study. BMC Musculoskeletal Disord 16(1):124
Lynch NA, Metter EJ, Lindle RS et al (1999) Muscle quality I Age-associated differences between arm and leg muscle groups. J Appl Physiol. 86(1):188–194
Blondell S, Hammersley-Mather R, Lennert VJ (2014) Does physical activity prevent cognitive decline and dementia? A systematic review and meta-analysis of longitudinal studies. BMC Public Health. https://doi.org/10.1186/1471-2458-14-510
Steffl M, Bohannon RW, Petr M, Kohlikova E, Holmerova I (2015) Relation between cigarette smoking and sarcopenia: meta-analysis. Physiol Res 64(3):419–426
Rom O, Kaisari S, Aizenbud D, Reznick AZ (2012) Sarcopenia and smoking: a possible cellular model of cigarette smoke effects on muscle protein breakdown. Ann N Y Acad Sci 1259(1):47–53
Reitz C, Luchsinger J, Tang M-X, Mayeux R (2005) Effect of smoking and time on cognitive function in the elderly without dementia. Neurology 65(6):870–875
Addison O, Drummond MJ, LaStayo PC et al (2014) Intramuscular fat and inflammation differ in older adults: the impact of frailty and inactivity. J Nutr Health Aging 18(5):532–538
Nguyen JC, Killcross AS, Jenkins TA (2014) Obesity and cognitive decline: role of inflammation and vascular changes. Front Neurosci 8:375
Mora M, Granada ML, Palomera E, Serra-Prat M, Puig-Domingo M (2013) Obestatin is associated to muscle strength, functional capacity and cognitive status in old women. Age (Dordr) 35(6):2515–2523
Wolowczuk I (2015) Obesity – an inflammatory state. Acta Vet Scand 57(1):K5
Balter LJT, Higgs S, Aldred S, Bosch JA, Raymond JE (2019) Inflammation mediates body weight and ageing effects on psychomotor slowing. Sci Rep 9(1):15727–15727
Schaap LA, Pluijm SM, Deeg DJ et al (2009) Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 64(11):1183–1189
Acknowledgements
We acknowledge the men who participated in the study, and the staff who contributed to the data collection. The authors thank Professor Graham Giles of the Cancer Epidemiology Centre of The Cancer Council Victoria, for permission to use the Dietary Questionnaire for Epidemiological Studies (Version 2), Melbourne: The Cancer Council Victoria 1996.
Funding
The Geelong Osteoporosis Study was funded by the National Health and Medical Research Council (NHMRC) Australia (projects 251638, 628582). The funding organisations played no role in the design or conduct of the study, in the collection, management, analysis and interpretation of the data, nor in the preparation, review and approval of the manuscript.
Author information
Authors and Affiliations
Contributions
All authors take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: JAP, LJW, SXS. Drafting of the manuscript: SXS. Acquisition, analysis, or interpretation of data: all authors. Critical revision of the manuscript for important intellectual content: all authors. Statistical analysis: SXS, JAP. Supervision: JAP, LJW, KLH-K and NKH.
Corresponding author
Ethics declarations
Conflict of interest
Sophia X. Sui was supported by a Deakin Postgraduate Scholarship in conjunction with the Geelong Medical and Hospital Benefits Association (GMHBA); Lana J. Williams by a NHMRC Career Development Fellowship (1064272) and a NHMRC Investigator grant (1174060); Kara L. Holloway‑Kew by an Alfred Deakin Postdoctoral Research Fellowship; Natalie K. Hyde by a Dean’s Research Postdoctoral Fellowship (Deakin University); Kara B. Anderson by an Australian Government Research Training Program (RTP) Scholarship and MCT by a Deakin Postgraduate Scholarship. Sarah Leach is General Manager Health, People and Community in the Geelong Medical and Hospital Benefits Association (GMHBA) and is an Adjunct Associate Professor in the Office of the Faculty of Health, at Deakin University. JAP has received speaker fees from Amgen, Eli Lilly and Sanofi-Aventis and funding from the National Health and Medical Research Council (NHMRC), Barwon Health, Deakin University, Amgen, the BUPA Foundation, Osteoporosis Australia, Australia and New Zealand Bone and Mineral Society, the Geelong Community Foundation, the Western Alliance, and the Norman Beischer Foundation. Alex B. Addinsall declares that no competing interests exist.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Human Research Ethics Committee at Barwon Health.
Human and Animal Rights and Informed Consent
All participants provided written informed consent to participate in the study. The study was approved by the Human Research Ethics Committee at Barwon Health.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sui, S.X., Williams, L.J., Holloway-Kew, K.L. et al. Skeletal Muscle Density and Cognitive Function: A Cross-Sectional Study in Men. Calcif Tissue Int 108, 165–175 (2021). https://doi.org/10.1007/s00223-020-00759-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-020-00759-3